Drug name - Tosymra

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8268791 UPSHER SMITH LABS Alkylglycoside compositions for drug administration May, 2026

(3 years from now)

US8440631 UPSHER SMITH LABS Compositions for drug administration May, 2026

(3 years from now)

US9283280 UPSHER SMITH LABS Compositions for drug administration May, 2026

(3 years from now)

US10603305 UPSHER SMITH LABS Formulations comprising triptan compounds Jun, 2030

(7 years from now)

US9974770 UPSHER SMITH LABS Formulations comprising triptan compounds Jun, 2030

(7 years from now)

US9610280 UPSHER SMITH LABS Formulations comprising triptan compounds Jun, 2030

(7 years from now)

US9211282 UPSHER SMITH LABS Formulations comprising triptan compounds Jul, 2031

(8 years from now)

Drugs and Companies using SUMATRIPTAN ingredient

Treatment: Acute treatment of migraine

Dosage: SPRAY;NASAL

More Information on Dosage
Strength Dosage Availability
10MG/SPRAY SPRAY;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.